Lipid A, monophosphoryl from Salmonella enterica Re 595

<strong>Lipid A, monophosphoryl from Salmonella enterica Re 595</strong>_x000D_ <strong>Catalog number:</strong> B2017393_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> N/A_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Hewawaduge C, Senevirathne A, Sivasankar C, Lee JH. The impact of lipid A modification on biofilm and related pathophysiological phenotypes, endotoxicity, immunogenicity, and protection of Salmonella Typhimurium Vet Microbiol. 2023 Jul;282:109759._x000D_ 2: Liu Q, Su H, Bian X, Wang S, Kong Q. Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a Int J Med Microbiol. 2020 Jul;310(5):151427._x000D_ 3: Qureshi N, Takayama K, Ribi E. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium J Biol Chem. 1982 Oct 10;257(19):11808-15._x000D_ 4: Takayama K, Qureshi N, Mascagni P. Complete structure of lipid A obtained from the lipopolysaccharides of the heptoseless mutant of Salmonella typhimurium J Biol Chem. 1983 Nov 10;258(21):12801-3._x000D_ 5: Qureshi N, Takayama K, Heller D, Fenselau C. Position of ester groups in the lipid A backbone of lipopolysaccharides obtained from Salmonella typhimurium J Biol Chem. 1983 Nov 10;258(21):12947-51._x000D_ 6: Wang YQ, Bazin-Lee H, Evans JT, Casella CR, Mitchell TC. MPL Adjuvant Contains Competitive Antagonists of Human TLR4 Front Immunol. 2020 Oct 16;11:577823._x000D_ 7: Ribi E, Cantrell JL, Takayama K, Qureshi N, Peterson J, Ribi HO. Lipid A and immunotherapy Rev Infect Dis. 1984 Jul-Aug;6(4):567-72._x000D_ 8: Baldrick P, Richardson D, Elliott G, Wheeler AW. Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant Regul Toxicol Pharmacol. 2002 Jun;35(3):398-413._x000D_ 9: Kong Q, Six DA, Roland KL, Liu Q, Gu L, Reynolds CM, Wang X, Raetz CR, Curtiss R 3rd. Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity J Immunol. 2011 Jul 1;187(1):412-23._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/6391653">10: Vosika GJ, Barr C, Gilbertson D. Phase-I study of intravenous modified lipid A Cancer Immunol Immunother. 1984;18(2):107-12. </a>_x000D_ _x000D_ <strong>Products Related to Lipid A, monophosphoryl from Salmonella enterica Re 595 can be found at</strong> <a href="https://moleculardepot.com/product-category/Lipids/"> Lipids</a>